These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29869039)

  • 1. Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY
    Osteoporos Int; 2018 Jul; 29(7):1505-1510. PubMed ID: 29869039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal-directed treatment of osteoporosis in Europe.
    Kanis JA; McCloskey E; Branco J; Brandi ML; Dennison E; Devogelaer JP; Ferrari S; Kaufman JM; Papapoulos S; Reginster JY; Rizzoli R
    Osteoporos Int; 2014 Nov; 25(11):2533-43. PubMed ID: 25199574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
    Harvey NC; McCloskey E; Kanis JA; Compston J; Cooper C
    Osteoporos Int; 2018 Jul; 29(7):1511-1513. PubMed ID: 29947864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
    Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
    Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
    Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
    Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment failure in osteoporosis.
    Diez-Perez A; Adachi JD; Agnusdei D; Bilezikian JP; Compston JE; Cummings SR; Eastell R; Eriksen EF; Gonzalez-Macias J; Liberman UA; Wahl DA; Seeman E; Kanis JA; Cooper C;
    Osteoporos Int; 2012 Dec; 23(12):2769-74. PubMed ID: 22836278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY;
    Osteoporos Int; 2019 Jan; 30(1):3-44. PubMed ID: 30324412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.
    Adler RA; Hastings FW; Petkov VI
    Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY;
    Aging Clin Exp Res; 2019 Jan; 31(1):15-17. PubMed ID: 30612282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging.
    Shevroja E; Reginster JY; Lamy O; Al-Daghri N; Chandran M; Demoux-Baiada AL; Kohlmeier L; Lecart MP; Messina D; Camargos BM; Payer J; Tuzun S; Veronese N; Cooper C; McCloskey EV; Harvey NC
    Osteoporos Int; 2023 Sep; 34(9):1501-1529. PubMed ID: 37393412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
    Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
    Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and use of FRAX in osteoporosis.
    Kanis JA; McCloskey EV; Johansson H; Oden A; Ström O; Borgström F
    Osteoporos Int; 2010 Jun; 21 Suppl 2():S407-13. PubMed ID: 20464374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRAX updates 2016.
    McCloskey EV; Harvey NC; Johansson H; Kanis JA
    Curr Opin Rheumatol; 2016 Jul; 28(4):433-41. PubMed ID: 27163858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines.
    Sale JEM; Gray M; Mancuso D; Inrig T; Boire G; Beaulieu MC; Funnell L; Bogoch E
    Rheumatol Int; 2018 Dec; 38(12):2193-2208. PubMed ID: 30367203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Good and the Bad About the 2017 American College of Physicians Osteoporosis Guidelines.
    Lagari V; Gavcovich T; Levis S
    Clin Ther; 2018 Jan; 40(1):168-176. PubMed ID: 29196083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and management of fracture risk in patients with Parkinson's disease.
    Lyell V; Henderson E; Devine M; Gregson C
    Age Ageing; 2015 Jan; 44(1):34-41. PubMed ID: 25236847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study.
    Berry SD; Kiel DP; Donaldson MG; Cummings SR; Kanis JA; Johansson H; Samelson EJ
    Osteoporos Int; 2010 Jan; 21(1):53-60. PubMed ID: 19937426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.